CTOs on the Move

Mary Ann Morse Healthcare Center

www.maryannmorse.org

 
Non-profit Mary Ann Morse Healthcare Corp. provides continuum of affordable, quality senior living and healthcare services in Metro West.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Sunset Nursing Home

Sunset Nursing Home is a Boonville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Grace Davison Discovery Sciences

Grace Davison Discovery Sciences is a Deerfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dungarvin

Dungarvin is a national organization of privately owned companies that are dedicated to providing high quality, community-based supports to people with varying support needs. Founded in St. Paul, Minnesota in 1976, Dungarvin has grown to employ approximately 3,500 people who currently provide supports to over 3,200 individuals across 13 states. We believe all persons faced with the challenges of a disability have the same rights and the same basic needs as do other citizens without disabilities. Dungarvin`s mission and values apply to every person we serve, including those with significant behavioral, medical and physical challenges. We are committed to principles of self-determination, self-actualization, and to the preservation of dignity of each person we serve, regardless of the nature or degree of their needs. Dungarvin`s mission is respecting and responding to the choices of people in need of supports. Dungarvin provides a variety of individually tailored services and supports including supported living, day services, supported employment, case management, supported foster care, children`s services, respite care, elder care, host homes and supports for persons with traumatic brain injury and mental health needs in several states.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.

Advion BioSciences, Inc.

Advion BioSciences, Inc. was founded in 1993 based on the novel techniques developed within the Cornell University laboratory of Dr. Jack Henion, a leading researcher in the field of Liquid Chromatography/Mass Spectrometry (LC/MS).